Metraipolis › archive › dc_7e3d87f57a9a

Hybrid Nanocarriers for Cancer Therapy: Advancements in Co-Delivery of Gene Therapy and Immunotherapy — Europe PMC PMID:41516128

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41516128
DOI
10.3390/ijms27010248
License (as archived)
solo-consultazione
Archived
2026-11-07T10:10:43.262Z
SHA-256 of the archived text
4746fb79e9110871b911786333245549027540851e3a73c928011563e1ab257d
Stable URL of this page
https://metraipolis.com/documento/dc_7e3d87f57a9a

How to cite

Hybrid Nanocarriers for Cancer Therapy: Advancements in Co-Delivery of Gene Therapy and Immunotherapy — Europe PMC PMID:41516128 — Europe PMC (en), https://europepmc.org/article/MED/41516128 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e3d87f57a9a (Metraipolis archive dc_7e3d87f57a9a, sha256 4746fb79e9110871b911786333245549027540851e3a73c928011563e1ab257d)
BibTeX
@misc{dc7e3d87f57a9a,
  title = {Hybrid Nanocarriers for Cancer Therapy: Advancements in Co-Delivery of Gene Therapy and Immunotherapy — Europe PMC PMID:41516128},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41516128},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e3d87f57a9a; sha256 4746fb79e9110871b911786333245549027540851e3a73c928011563e1ab257d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41516128. Agents can read the archived copy with the MCP tool read_document.